Übersetzung für "Disease biology" in Deutsch

We have made unprecedented progress in understanding disease biology and the immune system.

Each of the ‘Disease Biology Areas’ (DBAs) that will be created under the new model will combine all activities in a specific therapeutic field, from research and development to strategic marketing.

By combining existing expertise in Disease Biology Areas, we will further enhance the optimal conditions for bringing future innovations to fruition faster and more efficiently - with clear benefits for patients and doctors".Research sites around the world In addition to Basel, Nutley and Palo Alto, all other current research sites in the Roche network will continue to play an important role in creating innovation.

Hal Barron, currently SVP Genentech Development and Chief Medical Officer (CMO), will be appointed EVP Head Global Development responsible for Early and Late Development for three Disease Biology Areas (oncology, immunology/tissue growth repair, virology).

Third, participants have been selected largely ignoring their underlying disease biology, phenotypic variation and their genetic risk profile, resulting in a very heterogeneous population of cases with very different progression of disease.

It streamlines decision-making and links discovery, translational medicine, clinical development, diagnostic input and marketing in dedicated leadership teams for each of our five Disease Biology Areas.

Goal: Scientists need innovative technologies to better understand disease biology and, ultimately, enhance the discovery and development of new medicines.

For nearly 50 years, we have provided hospitals and laboratories with the diagnostic tests and instruments they need to better understand disease and patient biology.

Efforts such as these hold enormous promise to rapidly expand our knowledge of disease biology and, in turn, transform the treatment of disease through targeted diagnostic methods and medicines adapted to the genetic constitution of degenerated cells.

In the early stages of discovery, these biomarkers can provide us with insights on the disease biology and the mode of action of a therapeutic molecule.

Biomarker studies can help to understand disease biology and to identify patient subgroups with the highest unmet medical need.

The Disease Biology Area Leadership Teams (DBLTs) will be co-located in Basel, Nutley and Palo Alto.

This collaboration will enable Roche to conduct multidisciplinary studies and generate important insights in disease biology to accelerate the drug discovery and development process,” said Dr Beh Swan Gin, Managing Director, Singapore Economic Development Board.

Today Roche announced that it will be introducing a new operating model for its global research and development (R & D) activities, organised around Disease Biology Areas (DBA).

The rapidly expanding knowledge base of disease biology and of the causes of disease holds enormous potential to provide significant benefits to patients.

Advances in technology allow biomarker scientists to gather more data on drug response and disease biology than ever before.

It encompasses preclinical investigations of the biological effects of therapeutics as well as clinical investigations aimed at enhanced understanding of disease biology.

Human stem cells on the other hand have features that are directly linked to the diseased patients themselves, which can bring an additional level of confidence to a drug program or disease biology.

The DBAs will be headed by cross-functional Disease Biology Area Leadership Teams (DBLTs) based in Basel, Nutley and Palo Alto.

By creating tailored collaborations, we deliver deep insight into disease biology and the right tools to enhance the R & D efforts and product development of our partners.